V Odlind. Show Affiliations »
Abstract
Mesh: See more » Contraceptive Agents, Female/administration & dosageDrug ImplantsFemaleHumansIntrauterine Devices, MedicatedLevonorgestrelMedroxyprogesterone/administration & dosageMedroxyprogesterone/adverse effectsMedroxyprogesterone/analogs & derivativesMedroxyprogesterone/pharmacologyMedroxyprogesterone AcetateNorethindrone/administration & dosageNorethindrone/adverse effectsNorethindrone/analogs & derivativesNorethindrone/pharmacologyNorgestrel/administration & dosagePregnancyProgesterone/administration & dosageProgestins/administration & dosageResearchTime FactorsVagina
Substances: See more » Contraceptive Agents, FemaleDrug ImplantsProgestinsprogestasert (progesterone-IUD)NorgestrelProgesteroneLevonorgestrelMedroxyprogesterone AcetateMedroxyprogesteronenorethindrone enanthateNorethindrone
Year: 1986 PMID: 2949479 DOI: 10.3109/00016348609157047
Source DB: PubMed Journal: Acta Obstet Gynecol Scand Suppl ISSN: 0300-8835